Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CGT Landscape: Recent Approvals, Deals And 2024 Catalysts

Jan 22 2024

• By Lucie Ellis-Taitt

3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy) - Illustration — • Source: Shutterstock

Related Content

Vertex/CRISPR Nab First-Ever Gene Editing FDA Nod, Overshadow Bluebird’s Same-Day Win

Dec 09 2023

The ‘Haves And Have-Nots’ Are Becoming Clearer In Cell And Gene Therapy

Jan 16 2024

Related Companies

Vertex Pharmaceuticals Incorporated

CRISPR Therapeutics AG

AstraZeneca PLC

Gracell Biotechnologies Inc.

INVO Bioscience, Inc.

Selecta Biosciences, Inc.

Cartesian Therapeutics, Inc.

Additional Topics

Clinical Trials Deals Financing Gene Therapy Approvals Market Intelligence Regenerative Medicine Strategy Rare Diseases Cancer BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window